Facetten
Zugriff
Einrichtung
Medientyp
- Text 6
Karte
Erscheinungsjahr
Autor/in
- Goldschmidt, Hartmut
- Weisel, Katja
- DeCosta, Lucy 2
- Delforge, Michel 2
- Einsele, Hermann 2
- alle zeigen
Sprache
- Englisch 6
6 Einträge gefunden
-
MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel) in Lenalidomide-Refractory Patients With Progressive Multiple Myeloma (MM) After 1-3 Prior Lines of Therapy (LOT)
- Hillengass, Jens
- Cohen, Adam D
- Delforge, Michel
- Einsele, Hermann
- Goldschmidt, Hartmut
- Weisel, Katja
- Raab, Marc-Steffen
-
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
- Mateos, Maria-Victoria
- Weisel, Katja
- De Stefano, Valerio
- Goldschmidt, Hartmut
- Delforge, Michel
- Mohty, Mohamad
- Cavo, Michele
-
Carfilzomib 56 mg/m2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison
- Weisel, Katja
- Nooka, Ajay K
- Terpos, Evangelos
- Spencer, Andrew
- Goldschmidt, Hartmut
- Dirnberger, Franziska
- DeCosta, Lucy
-
-
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial
- Raab, Marc S
- Engelhardt, Monika
- Blank, Antje
- Goldschmidt, Hartmut
- Agis, Hermine
- Blau, Igor W
- Einsele, Hermann
-
Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials
- Weisel, Katja
- Majer, Istvan
- DeCosta, Lucy
- Oriol, Albert
- Goldschmidt, Hartmut
- Ludwig, Heinz
- Campioni, Marco